Insider Trading - Growth Equity Opportunities Fund IV LLC

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
    "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
    - Peter Lynch
    What is insider trading>>
    Time period:
    Insider Trading Transactions for Growth Equity Opportunities Fund IV LLC

    Common stock purchase or sale:
    Transaction
    Date
    Reported
    DateTime
    Company Symbol Insider
    Relationship
    Shares
    Traded
    Average
    Price
    Total
    Amount
    Shares
    Owned
    Filing
    2016-12-19
    Purchase
    2016-12-19
    4:43 pm
    Achaogen Inc AKAO Growth Equity Opportunities IV LLC
    New Enterprise Associates 15 L.P.
    NEA Partners 15 L.P.
    NEA 15 GP LLC
    10% Owner
    500,000 $13.5 $6,750,000 5,215,128
    (Direct)
    View
    2017-03-28
    Purchase
    2017-03-29
    4:09 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    6,000,000 $0.5 $3,000,000 16,362,694
    (Direct)
    View
    2018-02-26
    Sale
    2018-02-27
    4:34 pm
    ARCA biopharma Inc. ABIO Growth Equity Opportunities IV LLC
    New Enterprise Associates 15 L.P.
    NEA Partners 15 L.P.
    NEA 15 GP LLC
    10% Owner
    1,460,209 $0.5008 $731,273 0
    (Direct)
    View
    2018-04-06
    Purchase
    2018-04-10
    5:28 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    920,976 $2.2965 $2,115,036 17,283,670
    (Direct)
    View
    2018-05-08
    Purchase
    2018-05-10
    5:00 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    70,873 $2.1341 $151,250 17,354,544
    (Direct)
    View
    2018-05-17
    Purchase
    2018-05-21
    5:23 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    236,479 $2.1288 $503,423 17,591,022
    (Direct)
    View
    2018-05-30
    Purchase
    2018-05-30
    5:09 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    275 $2.15 $591 17,591,296
    (Direct)
    View
    2018-06-27
    Purchase
    2018-06-28
    7:09 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    192,425 $2.0999 $404,077 17,783,722
    (Direct)
    View
    2018-07-18
    Purchase
    2018-07-20
    4:40 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    250,600 $1.9623 $491,745 18,034,322
    (Direct)
    View
    2018-08-21
    Purchase
    2018-08-22
    4:42 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    663,716 $2.26 $1,499,998 18,698,038
    (Direct)
    View
    2018-11-15
    Purchase
    2018-11-19
    7:39 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    1,200,000 $1.865 $2,237,971 19,898,038
    (Direct)
    View
    2018-11-20
    Purchase
    2018-11-21
    4:41 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    170,000 $1.9771 $336,107 20,068,038
    (Direct)
    View
    2018-11-28
    Purchase
    2018-11-30
    5:10 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    96,400 $1.9802 $190,891 20,164,438
    (Direct)
    View
    2018-12-06
    Purchase
    2018-12-10
    5:18 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    170,400 $1.9856 $338,352 20,334,838
    (Direct)
    View
    2018-12-11
    Purchase
    2018-12-12
    4:40 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    61,200 $1.9785 $121,084 20,396,038
    (Direct)
    View
    2018-12-20
    Purchase
    2018-12-21
    9:15 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    500,000 $1.5489 $774,440 20,896,038
    (Direct)
    View
    2019-04-08
    Purchase
    2019-04-08
    5:18 pm
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities Fund IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    4,347,827 $1.14 $4,956,523 25,243,864
    (Direct)
    View
    2020-06-19
    Purchase
    2020-06-22
    5:26 pm
    AVEO PHARMACEUTICALS Inc AVEO Growth Equity Opportunities Fund IV LLC
    New Enterprise Associates 15 L.P.
    NEA Partners 15 L.P.
    NEA 15 GP LLC
    10% Owner
    1,428,571 $5.25 $7,499,998 3,952,958
    (Direct)
    View

    Stock options: Exercise, Award, Grant, Conversion
    Transaction
    Date
    Reported
    DateTime
    Exercisable
    Expiration
    Company Symnbol Insider
    Relationship
    Shares
    Traded
    Conversion
    Price
    Shares
    Owned
    Filing
    2018-02-20
    Conversion
    2018-02-22
    4:41 pm
    N/A
    N/A
    Cascadian Therapeutics Inc. CASC Growth Equity Opportunities IV LLC
    New Enterprise Associates 15 L.P.
    NEA Partners 15 L.P.
    NEA 15 GP LLC
    10% Owner
    1,818,000 $3.3 10,882,574
    (Direct)
    View
    2018-02-20
    Conversion
    2018-02-22
    4:41 pm
    N/A
    N/A
    Cascadian Therapeutics Inc. CASC Growth Equity Opportunities IV LLC
    New Enterprise Associates 15 L.P.
    NEA Partners 15 L.P.
    NEA 15 GP LLC
    10% Owner
    1,818,000 $0 0
    (Direct)
    View
    2018-03-09
    Equity Swap
    2018-03-13
    6:06 pm
    N/A
    N/A
    Cascadian Therapeutics Inc. CASC Growth Equity Opportunities IV LLC
    New Enterprise Associates 15 L.P.
    NEA Partners 15 L.P.
    NEA 15 GP LLC
    10% Owner
    10,882,574 $0 0
    (Direct)
    View
    2019-04-08
    Purchase
    2019-04-08
    5:18 pm
    2019-04-08
    2021-04-08
    AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities Fund IV LLC
    NEA 15 GP LLC
    NEA Partners 15 L.P.
    New Enterprise Associates 15 L.P.
    10% Owner
    4,347,827 $0.01 4,347,827
    (Direct)
    View